These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16310901)

  • 1. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.
    Mancini-Bourgine M; Fontaine H; Bréchot C; Pol S; Michel ML
    Vaccine; 2006 May; 24(21):4482-9. PubMed ID: 16310901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.
    Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Bréchot C; Michel ML
    Hepatology; 2004 Oct; 40(4):874-82. PubMed ID: 15382173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO; Herzog-Hauff S; Schlaak J; Meyer zum Büschenfeld KH; Löhr HF
    Hepatology; 1999 Jan; 29(1):238-44. PubMed ID: 9862872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
    J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific T cell immune response in chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine].
    Xu QH; Zhang XH; Xie DY; Li JG; Chong YT; Yang L; Lu WL; Gao ZL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):334-6. PubMed ID: 18322594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study.
    Yang SH; Lee CG; Park SH; Im SJ; Kim YM; Son JM; Wang JS; Yoon SK; Song MK; Ambrozaitis A; Kharchenko N; Yun YD; Kim CM; Kim CY; Lee SH; Kim BM; Kim WB; Sung YC
    Gene Ther; 2006 Jul; 13(14):1110-7. PubMed ID: 16525482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.
    Couillin I; Pol S; Mancini M; Driss F; Bréchot C; Tiollais P; Michel ML
    J Infect Dis; 1999 Jul; 180(1):15-26. PubMed ID: 10353856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy.
    Yang FQ; Yu YY; Wang GQ; Chen J; Li JH; Li YQ; Rao GR; Mo GY; Luo XR; Chen GM
    J Viral Hepat; 2012 Aug; 19(8):581-93. PubMed ID: 22762143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.
    Mancini M; Hadchouel M; Tiollais P; Michel ML
    J Immunol; 1998 Nov; 161(10):5564-70. PubMed ID: 9820533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers.
    Xiong SQ; Lin BL; Gao X; Tang H; Wu CY
    Int Immunopharmacol; 2007 May; 7(5):578-87. PubMed ID: 17386405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
    Li X; Yang X; Jiang Y; Liu J
    Int Immunol; 2005 Oct; 17(10):1293-302. PubMed ID: 16113237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
    Wang J; Gujar SA; Cova L; Michalak TI
    J Virol; 2007 Jan; 81(2):903-16. PubMed ID: 17079319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of hepatitis B virus (HBV) vaccination in treating lamivudine-resistant HBV reactivation following hepatitis B surface antigen seroconversion.
    Gérolami R; Borentain P; Colson P; Norguet E; Gérolami A; Tamalet C
    Liver Int; 2007 Dec; 27(10):1417-21. PubMed ID: 18036104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.
    Zheng BJ; Zhou J; Qu D; Siu KL; Lam TW; Lo HY; Lee SS; Wen YM
    J Viral Hepat; 2004 May; 11(3):217-24. PubMed ID: 15117323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
    Safadi R; Israeli E; Papo O; Shibolet O; Melhem A; Bloch A; Rowe M; Alper R; Klein A; Hemed N; Segol O; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Am J Gastroenterol; 2003 Nov; 98(11):2505-15. PubMed ID: 14638356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and humoral immune response to a third generation hepatitis B vaccine.
    Schumann A; Fiedler M; Dahmen U; Grosse-Wilde H; Roggendorf M; Lindemann M
    J Viral Hepat; 2007 Aug; 14(8):592-8. PubMed ID: 17650294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
    Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination.
    Castellanos M; Cinza Z; Dorta Z; Veliz G; Vega H; Lorenzo I; Ojeda S; Dueñas-Carrera S; Alvarez-Lajonchere L; Martínez G; Ferrer E; Limonta M; Linares M; Ruiz O; Acevedo B; Torres D; Márquez G; Herrera L; Arús E
    J Gene Med; 2010 Jan; 12(1):107-16. PubMed ID: 19866482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.